Lusitropic and anti-hypertrophic effects of the sphingosine-1-phosphate receptor modulator, FTY720, in hypertrophic cardiomyopathy

被引：0
|
作者：
Ryba, D. M. [1 ,2 ]
Warren, C. M. [1 ,2 ]
Karam, C. N. [1 ,2 ]
Davis, R. T., III [1 ,2 ]
Chowdhury, S. A. K. [1 ,2 ]
Alvarez, M. G. [1 ,2 ]
Wieczorek, D. F. [3 ]
Solaro, R. J. [1 ,2 ]
Wolska, B. M. [1 ,2 ,4 ]
机构：
[1] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA
[2] Univ Illinois, Coll Med, Ctr Cardiovasc Res, Chicago, IL USA
[3] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA
[4] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2017年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
32
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] The Sphingosine-1-Phosphate Receptor Modulator, FTY720, Reverses Diastolic Dysfunction and Hypertrophy in Hypertrophic Cardiomyopathy
    Ryba, David M.
    Warren, Chad M.
    Karam, Chehade N.
    Dovis, Robert T., III
    Chowdhury, Shamim A. K.
    Alvarez, Manuel G.
    Wieczorek, David F.
    Solaro, R. John
    Wolska, Beata M.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 112 : 156 - 157
  • [2] The Sphingosine-1-Phosphate Analog, FTY720, Reverses Diastolic Dysfunction and Hypertrophy in Familial Hypertrophic Cardiomyopathy
    Ryba, David M.
    Warren, Chad M.
    Karam, Chehade N.
    Davis, Robert T., III
    Chowdhury, Shamim A. K.
    Alvarez, Manuel G.
    Wieczorek, David F.
    Solaro, R. John
    Wolska, Beata M.
    [J]. FASEB JOURNAL, 2017, 31
  • [3] Human islet function is not impaired by the sphingosine-1-phosphate receptor modulator FTY720
    Truong, W.
    Emamaullee, J. A.
    Merani, S.
    Anderson, C. C.
    Shapiro, A. M. James
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (08) : 2031 - 2038
  • [4] The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity
    Bandhuvula, P
    Tam, YY
    Oskouian, B
    Lucas, A
    Saba, JD
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2006, 79 (1-2) : 160 - 160
  • [5] The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity
    Bandhuvula, P
    Tam, YY
    Oskouian, B
    Saba, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (40) : 33697 - 33700
  • [6] Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation
    Tsai, Hsing-Chuan
    Huang, Yingxiang
    Garris, Christopher S.
    Moreno, Monica A.
    Griffin, Christina W.
    Han, May H.
    [J]. JCI INSIGHT, 2016, 1 (09)
  • [7] Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds
    Toelle, M.
    Levkau, B.
    Kleuser, B.
    van der Giet, M.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (03) : 171 - 179
  • [8] Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy
    Ryba, David M.
    Warren, Chad M.
    Karam, Chehade N.
    Davis, Robert T., III
    Chowdhury, Shamim A. K.
    Alvarez, Manuel G.
    McCann, Maximilian
    Liew, Chong Wee
    Wieczorek, David F.
    Varga, Peter
    Solaro, R. John
    Wolska, Beata M.
    [J]. CIRCULATION-HEART FAILURE, 2019, 12 (11)
  • [9] The sphingosine-1-phosphate receptor modulator, FTY720, prevents the incidence of diabetes in Spontaneously Diabetic Torii rats
    Kobayashi, Kazuma
    Sasase, Tomohiko
    Ishii, Yukihito
    Katsuda, Yoshiaki
    Miyajima, Katsuhiro
    Yamada, Takahisa
    Ohta, Takeshi
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (06) : 869 - 876
  • [10] Effect of the sphingosine-1-phosphate receptor modulator FTY720 on the outcome in a mouse model of focal cortical cryolesion
    Albert-Weissenberger, C.
    Hennig, N.
    Siren, A. -L.
    Kleinschnitz, C.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S119 - S120
12345